$CEL-SCI (CVM.US)$ NEWS CEL-SCI Receives FDA Go-Ahead for It...
NEWS
CEL-SCI Receives FDA Go-Ahead for Its Confirmatory Study of Multikine in the Treatment of Head & Neck Cancer
CEL-SCI has received FDA approval for a confirmatory study of its cancer immunotherapy Multikine for head and neck cancer patients, based on strong Phase 3 data showing a 73% survival rate with Multikine. The study will enroll 212 patients and aims to confirm the results of the Phase 3 trial, paving the way for potential approval. The FDA acknowledged the unmet need for improved therapies in this patient population, supporting approval for Multikine.
Positive
FDA approved CEL-SCI's confirmatory study for Multikine based on strong Phase 3 data showing a 73% survival rate with Multikine.
The confirmatory study will enroll 212 patients, demonstrating a clear path forward for potential approval.
CEL-SCI's de-risked value proposition for investors presents a unique opportunity in the oncology sector with a large body of data showing positive results in the target patient population.
CEL-SCI has received FDA approval for a confirmatory study of its cancer immunotherapy Multikine for head and neck cancer patients, based on strong Phase 3 data showing a 73% survival rate with Multikine. The study will enroll 212 patients and aims to confirm the results of the Phase 3 trial, paving the way for potential approval. The FDA acknowledged the unmet need for improved therapies in this patient population, supporting approval for Multikine.
Positive
FDA approved CEL-SCI's confirmatory study for Multikine based on strong Phase 3 data showing a 73% survival rate with Multikine.
The confirmatory study will enroll 212 patients, demonstrating a clear path forward for potential approval.
CEL-SCI's de-risked value proposition for investors presents a unique opportunity in the oncology sector with a large body of data showing positive results in the target patient population.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
596Followers
70Following
3788Visitors
Follow